Brought to you by 
UCB teams up with 4SC, Crelux for neurological compounds
22 Aug 2013
Executive Summary
UCB Group has teamed up with drug discovery firms 4SC Discovery GMBH and Crelux GMBH to identify and validate small molecules to treat neurological disorders.
Deal Industry
- Pharmaceuticals
- Services
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
UCB teams up with 4SC, Crelux for neurological compounds
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice